-transparent.png){kind=logo}
Anticyan is a highly effective antidote of cyanic acid and cyanide-containing compounds. It was created at the Institute of Pharmacology and Toxicology of AMS of Ukraine. Anticyan differs from other existing cyanide antidotes in that it possesses a tready methemoglobin-formation activity, has no hypotensive effect and is capable of direct stimulation of cyanide-inhibited tissue respiration.
Related Publications
F P Trinus, and
A V Chubenko, and
T V Pedchenko
March 1997,
Lakartidningen,
F P Trinus, and
A V Chubenko, and
T V Pedchenko
May 2008,
Voenno-meditsinskii zhurnal,
F P Trinus, and
A V Chubenko, and
T V Pedchenko
November 1985,
The American journal of emergency medicine,
F P Trinus, and
A V Chubenko, and
T V Pedchenko
November 2006,
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,
F P Trinus, and
A V Chubenko, and
T V Pedchenko
November 1997,
Lakartidningen,
F P Trinus, and
A V Chubenko, and
T V Pedchenko
February 2023,
Proceedings of the National Academy of Sciences of the United States of America,
F P Trinus, and
A V Chubenko, and
T V Pedchenko
January 1990,
Veterinary research communications,
F P Trinus, and
A V Chubenko, and
T V Pedchenko
December 1974,
Lancet (London, England),
F P Trinus, and
A V Chubenko, and
T V Pedchenko
December 2016,
Journal of medical toxicology : official journal of the American College of Medical Toxicology,
F P Trinus, and
A V Chubenko, and
T V Pedchenko
October 1962,
California medicine,
